Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Felgner, SebastianKocijancic, Dino
Frahm, Michael
Heise, Ulrike
Rohde, Manfred
Zimmermann, Kurt
Falk, Christine
Erhardt, Marc

Weiss, Siegfried

Issue Date
2017-09-29
Metadata
Show full item recordCitation
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy 2017:e1382791 OncoImmunologyAffiliation
Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr.7, 38124 Braunschweig, Germany.Journal
OncoImmunologyAdditional Links
https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1382791Type
ArticleISSN
2162-402Xae974a485f413a2113503eed53cd6c53
10.1080/2162402X.2017.1382791
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/